Mr. Ziad Ghanem reports
TERRASCEND RESCHEDULES NOVEMBER 6TH THIRD QUARTER 2025 EARNINGS CONFERENCE CALL TO PRE-OPEN FROM POST-MARKET CLOSE
Terrascend Corp. has rescheduled its Nov. 6, 2025, earnings conference call to discuss the results for the third quarter ended Sept. 30, 2025. The call will still be held on Thursday, Nov. 6, 2025, but will take place at 8:30 a.m. Eastern Time. The company will release its financial results for the third quarter of 2025 on the same day in advance of the call. The rescheduling is due to a conflict with the originally scheduled time.
Revised conference call details
Date: Thursday, Nov. 6, 2025
Time: 8:30 a.m. Eastern Time
Webcast: A webcast will be available.
Dial-in number: 1-888-510-2154
Replay: 1-289-819-1450 or 1-888-660-6345 (available until 12 a.m. Eastern Time on Thursday, Nov. 20, 2025, replay entry code 73897 followed by the pound key)
About Terrascend
Corp.
Terrascend is a leading Toronto Stock Exchange-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio and California through Terrascend Growth Corp. and retail operations in Canada. Terrascend operates The Apothecarium and other dispensary retail locations, as well as scaled cultivation, processing and manufacturing facilities in its core markets. Terrascend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The company owns or licenses several synergistic businesses and brands, including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana and Valhalla Confections.
© 2026 Canjex Publishing Ltd. All rights reserved.